To further testify the role of SHH signaling in phenotype changes of ESCC cells, Cyclopamine, the inhibitor of SHH signaling pathway, was used to treat TE‐1 cells with or without the presence of CAFs‐derived exosomes. The gene discussed is SHH; the disease is esophageal squamous cell carcinoma.